Microbicides Research, Development, and Introduction

The summary for the Microbicides Research, Development, and Introduction grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Agency for International Development, which is the U.S. government agency offering this grant.

Microbicides Research, Development, and Introduction: Clinical trials of vaginal microbicide have been tested recently in South Africa to determine efficacy of reduction of HIV infection. Microbicide research, development, and introduction activities which could potentially be supported through this APS mechanism are expected to contribute substantially to the Principles of the Global Health Initiative (GHI), particularly in promoting research and innovation; implementing a woman- and girl-centered approach; strengthening and leveraging inputs from multilateral organizations, global health partnerships, and the private sector; and encouraging country ownership and leadership. Potential activities could also contribute significantly to strengthening the health system building blocks related to commodities and procurement, service delivery, and leadership and governance. It is expected that gender analyses and other gender considerations will continue to inform the design and implementation of activities implemented as part of the Agency's microbicide program. All awards will also be subject to USAID environmental requirements, including completion of an initial environmental examination. See attached APS for full Funding Opportunity description.

Federal Grant Title:	Microbicides Research, Development, and Introduction
Federal Agency Name:	Agency for International Development
Grant Categories:	Other
Type of Opportunity:	Other
Funding Opportunity Number:	APS-OAA-12-000007
Type of Funding:	Cooperative Agreement
CFDA Numbers:	98.001
CFDA Descriptions:	USAID Foreign Assistance for Programs Overseas
Current Application Deadline:	TBD
Original Application Deadline:	TBD
Posted Date:	Jul 30, 2012
Creation Date:	Jul 30, 2012
Archive Date:	No date given
Total Program Funding:
Maximum Federal Grant Award:	$2,250,000
Minimum Federal Grant Award:	$100,000
Expected Number of Awards:
Cost Sharing or Matching:	No

Category Explanation: Clinical trials of vaginal microbicide have been tested recently in South Africa to determine efficacy of reduction of HIV infection. Microbicide research, development, and introduction activities which could potentially be supported through this APS mechanism are expected to contribute substantially to the Principles of the Global Health Initiative (GHI), particularly in promoting research and innovation; implementing a woman- and girl-centered approach; strengthening and leveraging inputs from multilateral organizations, global health partnerships, and the private sector; and encouraging country ownership and leadership. Potential activities could also contribute significantly to strengthening the health system building blocks related to commodities and procurement, service delivery, and leadership and governance. It is expected that gender analyses and other gender considerations will continue to inform the design and implementation of activities implemented as part of the Agency’s microbicide program. All awards will also be subject to USAID environmental requirements, including completion of an initial environmental examination. This APS is intended to support the creative research and other innovative activities that are now essential to advance potential microbicides toward regulatory approval and then to successfully introduce them into delivery programs. Attaining these objectives will fill a critical gap in the options women and girls currently have to protect themselves from HIV infection.
Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Elibility requirements included in attached document.
Grant Announcement Contact: Kathleen Bumpass Contracts Specialist Phone 202-567-5008

Agreement Specialist [[email protected]]
Similar Government Grants: • Promoting Human Rights in Armenia; • Strengthening Civic Engagement in Kazakhstan; • RFi - Improved Access to Early Childhood Education and Employment Activity; • LAC Regional Fund to Expand Inclusive Access to Quality Basic Education; • Global Resilience Against Drug-Resistant Tuberculosis (GRAD-TB); • Textbook and Learning Materials Program; • Field-Support Program; • FY-2005 Disaster Response Initiative in Northeast Sudan; • NPI Annual Program Statement (New Partnerships Initiative (NPI)/Conflict Prevention and Re...; • YODA-7200AA20APS00007_Addendum; • Development Innovation Ventures: Stage 4 Awards Annual Program Statement (APS)